Vice President Mike Pence, who’s heading up the Trump administration’s response to the coronavirus, flew to 3M headquarters Thursday to meet the maker of the highly sought-after N95 face masks. The company is slated to produce 35 million more masks per month to meet growing demand.
Coronavirus update: Markets tank as 'it becomes harder to reassure' a jittery public
Gilead Sciences and Quest Diagnostics are pushing to accelerate the timetable for new testing and treatment methods.
Gilead is rolling out its clinical trials globally, with more sites to be announced soon, while Quest announced on Thursday it will be ready to test samples sent to its California lab by March 9 — with more locations rolling out the capability soon.